Literature DB >> 8629889

Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression.

J S Purba1, W J Hoogendijk, M A Hofman, D F Swaab.   

Abstract

BACKGROUND: Cerebrospinal fluid levels of arginine vasopressin (AVP) and oxytocin (OXT) have been found to change in mood disorders. In the present study, the numbers of AVP-immunoreactive (IR) and OXT-IR neurons were determined in the paraventricular nucleus (PVN) of the human hypothalamus.
METHODS: Postmortem brain tissue was fixed in formalin, embedded in paraffin, and stained for AVP and OXT using immunocytochemical techniques. The number of IR neurons in the PVN was estimated by morphometry in eight depressed patients ranging in age from 21 to 85 years and eight age-matched controls ranging in age from 23 to 88 years.
RESULTS: The numbers of AVP-IR and OXT-IR neurons in the PVN of patients with mood disorder were increased by 56% and 23%, respectively. No differences were found in AVP-IR or OXT-IR cell numbers between three patients with major depression and three patients with bipolar depression. The numbers of AVP-IR and OXT-IR neurons in two patients with depression not otherwise specified were within the same range as in the six other patients with a mood disorder.
CONCLUSIONS: The AVP and OXT neurons were activated in the PVN in patients with major depression or bipolar disorder. This activation may be associated with activation of the hypothalamic-pituitary-adrenal axis in these patients, since both AVP and OXT are known to potentiate the effects of corticotropin-releasing hormone. Because of their central effects, activation of AVP and OXT neurons may also be related to symptoms of major depression or bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8629889     DOI: 10.1001/archpsyc.1996.01830020055007

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  76 in total

1.  The Utility of Animal Models in Understanding Links between Psychosocial Processes and Cardiovascular Health.

Authors:  Angela J Grippo
Journal:  Soc Personal Psychol Compass       Date:  2011-04

2.  Relation of Promoter Methylation of the Oxytocin Gene to Stressful Life Events and Depression Severity.

Authors:  Simon Sanwald; Maximilian Gahr; Katharina Widenhorn-Müller; Carlos Schönfeldt-Lecuona; Kerstin Richter; Bernhard J Connemann; Thomas Kammer; Christian Montag; Markus Kiefer
Journal:  J Mol Neurosci       Date:  2019-11-25       Impact factor: 3.444

Review 3.  Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning?

Authors:  Guy Griebel; Florian Holsboer
Journal:  Nat Rev Drug Discov       Date:  2012-05-18       Impact factor: 84.694

Review 4.  [New insights into the pathogenesis and pathophysiology of depression].

Authors:  C Schüle; T C Baghai; R Rupprecht
Journal:  Nervenarzt       Date:  2007-11       Impact factor: 1.214

5.  Antidepressant and anxiolytic profiles of newly synthesized arginine vasopressin V1B receptor antagonists: TASP0233278 and TASP0390325.

Authors:  M Iijima; T Yoshimizu; T Shimazaki; K Tokugawa; K Fukumoto; S Kurosu; T Kuwada; Y Sekiguchi; S Chaki
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739

Review 6.  The role of oxytocin in psychiatric disorders: a review of biological and therapeutic research findings.

Authors:  David M Cochran; Daniel Fallon; Michael Hill; Jean A Frazier
Journal:  Harv Rev Psychiatry       Date:  2013 Sep-Oct       Impact factor: 3.732

Review 7.  Penetration of the blood-brain barrier by peripheral neuropeptides: new approaches to enhancing transport and endogenous expression.

Authors:  M R Lee; R D Jayant
Journal:  Cell Tissue Res       Date:  2018-12-10       Impact factor: 5.249

Review 8.  Endocrine disturbances in depression.

Authors:  M A Tichomirowa; M E Keck; H J Schneider; M Paez-Pereda; U Renner; F Holsboer; G K Stalla
Journal:  J Endocrinol Invest       Date:  2005-01       Impact factor: 4.256

Review 9.  The neurobiology of treatment response to antidepressants and mood stabilizing medications.

Authors:  L Trevor Young; David Bakish; Serge Beaulieu
Journal:  J Psychiatry Neurosci       Date:  2002-07       Impact factor: 6.186

10.  Family-based study of AVPR1B association and interaction with stressful life events on depression and anxiety in suicide attempts.

Authors:  Yair J Ben-Efraim; Danuta Wasserman; Jerzy Wasserman; Marcus Sokolowski
Journal:  Neuropsychopharmacology       Date:  2013-02-19       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.